Table 1.
Baseline characteristics of the included patients.
| Parameter | Control Group (n = 33) |
Intervention Group (n =34) | p Value | Total (n = 67) |
|---|---|---|---|---|
| Sex (men), n (%) | 18 (55) | 20 (59) | 0.35 | 38 (57) |
| Age (years), mean (SD) | 73.3 (10.3) | 71.8 (14.2) | 0.91 | 72.5 (12.3) |
| Number of drugs, mean (SD) | 10.5 (4.0) | 9.3 (3.2) | 0.18 | 9.9 (3.7) |
| Regular drugs, mean (SD) | 8.8 (3.4) | 7.3 (3.1) | 0.063 | 8.0 (3.3) |
| Pro re nata drugs, mean (SD) | 1.9 (1.4) | 2.0 (1.5) | 0.78 | 1.9 (1.5) |
| eGFR (mL/min/1.73m2), mean (SD) | 66.2 (18.5) | 68.9 (18.4) | 0.55 | 67.6 (18.4) |
| Comorbidities, mean (SD) | 4.5 (1.4) | 4.3 (1.4) | 0.56 | 4.4 (1.4) |
| Acute admission within 30 days, n (%) Acute admission within 90 days, n (%) Acute admission within 180 days, n (%) |
8 (23.2) 14 (42.4) 21 (63.6) |
3 (8.8) 9 (26.5) 13 (38.2) |
0.11 0.20 0.052 |
11 (16.4) 25 (34.3) 34 (50.7) |
1 SD, standard deviation; eGFR, estimated glomerular filtration rate.